Acclinate, a Birmingham, Alabama-based healthcare technology company, has completed a $7 million Series A funding round. The funding round, led by Cencora Ventures and supported by Labcorp and Latimer Ventures, aimed to enhance Acclinate’s efforts to promote health equity and transform the inclusivity of clinical trials. Transforming Clinical Trials through Trust and Technology Acclinate’s strategy aims to build trust and foster long-term relationships with diverse communities. Their digital platform, NOWINCLUDED, is designed to educate and engage underrepresented groups in clinical trials, ensuring their inclusion in medical research. The platform serves as an educational tool while
Twin Health has secured $50 million in funding for its AI-driven personalized healthcare tech that aims to prevent and reverse chronic health diseases like diabetes. Temasek led the Series D funding round with the participation of existing investors ICONIQ Growth, Sofina, Peak XV, and Helena. Twin Health was co-founded in 2018 by Jahangir Mohammed (CEO), also the founder of Jasper and Kineto Wireless, and Terry Poon (CTO). A whole-body digital twin Central to Twin Health’s mission is the Whole Body Digital Twin™ – an innovative, AI-driven healthcare platform that composes
Waspito, a Cameroonian health startup, has secured a $2.5 million seed extension, helping its growth in Francophone African regions. Waspito Waspito is a health-focused social network that aims to integrate the whole health ecosystem into a single platform. Instead of building a platform involving pre-registration and booking consultation meetings, founder Jean Lobe Lobe opted for one where users could instantly connect with doctors. Lobe founded the startup in 2020, just before the COVID pandemic became a global health emergency, aiming to make healthcare accessible. “Going online to book an appointment
